Cva Family Office, LLC Repligen Corp Transaction History

Cva Family Office, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	SELL	$108.89 - $145.23 $326 - $435	-3 Reduced 42.86%	4 $0
Q1 2025 Apr 16, 2025	BUY	$127.24 - $174.24 $381 - $522	3 Added 75.0%	7 $0
Q3 2024 Oct 10, 2024	BUY	$119.79 - $167.35 $479 - $669	4 New	4 $0
Q2 2022 Jul 11, 2022	SELL	$140.68 - $188.02 $8,440 - $11,281	-60 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$247.59 - $304.47 $14,855 - $18,268	60 New	60 $16,000

Q3 2021 Oct 12, 2021	SELL	$194.77 - $324.21 $14,607 - $24,315	-75 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$165.87 - $220.95 $12,440 - $16,571	75 New	75 $15,000

520

58.7M

321K

667K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.46B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Cva Family Office, LLC with notifications on news.